Literature DB >> 1589307

Comparison of nap and overnight polysomnography in children.

C L Marcus1, T G Keens, S L Ward.   

Abstract

Overnight polysomnography is the "gold standard" for diagnosing sleep-disordered breathing. However, the limited number of resources for pediatric polysomnography make the availability of a screening test for sleep-disordered breathing highly desirable. Therefore, we compared 1 hour daytime nap polysomnography to overnight polysomnography in 40 children [mean age, 5.4 +/- 0.8 (SE) years] with sleep-disordered breathing; 76% of children were sedated with chloral hydrate for nap polysomnography; none was sedated for overnight polysomnography. Studies were done 26 +/- 4 days apart. Chest wall motion, ECG, end-tidal PCO2 (PETCO2), arterial oxygen saturation (SaO2), and electrooculogram were monitored. Nap studies had a sensitivity of 74%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 17% in predicting sleep-disordered breathing. Significantly more children had obstructive apnea and desaturation (SaO2 less than 90%) during overnight polysomnography. The peak PETCO2 and the SaO2 nadir were significantly worse during overnight polysomnography. However, the percentage of time during which abnormalities were manifested did not differ between nap and overnight polysomnography. Despite the use of sedation, nap polysomnography underestimated sleep-disordered breathing. We conclude that sleep-disordered breathing detected by nap polysomnography is always confirmed by overnight polysomnography and speculate that nap polysomnography may be an effective screening method for sleep-disordered breathing. However, overnight polysomnography should be performed if nap polysomnography is inconclusive. Chloral hydrate may be used effectively to facilitate sleep for nap polysomnography in children.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1589307     DOI: 10.1002/ppul.1950130106

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  12 in total

Review 1.  Who should have a sleep study for sleep related breathing disorders?

Authors:  L Whiteford; P Fleming; A J Henderson
Journal:  Arch Dis Child       Date:  2004-09       Impact factor: 3.791

Review 2.  Sleep . 8: paediatric obstructive sleep apnoea.

Authors:  G M Nixon; R T Brouillette
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

3.  Timing, number and complexities of sleep studies.

Authors:  K P Strohl
Journal:  Sleep Breath       Date:  1997-06       Impact factor: 2.816

4.  The child's rumbling slumber.

Authors:  David Hiestand; Barbara Phillips
Journal:  J Clin Sleep Med       Date:  2011-06-15       Impact factor: 4.062

Review 5.  Executive summary of respiratory indications for polysomnography in children: an evidence-based review.

Authors:  Merrill S Wise; Cynthia D Nichols; Madeleine M Grigg-Damberger; Carole L Marcus; Manisha B Witmans; Valerie G Kirk; Lynn A D'Andrea; Timothy F Hoban
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

6.  Practice parameters for the respiratory indications for polysomnography in children.

Authors:  R Nisha Aurora; Rochelle S Zak; Anoop Karippot; Carin I Lamm; Timothy I Morgenthaler; Sanford H Auerbach; Sabin R Bista; Kenneth R Casey; Susmita Chowdhuri; David A Kristo; Kannan Ramar
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

7.  Diagnostic Approaches to Childhood Obstructive Sleep Apnea Hypopnea Syndrome.

Authors:  Carol Rosen
Journal:  Sleep Breath       Date:  2000       Impact factor: 2.816

8.  PEDIATRIC POLYSOMNOGRAPHY.

Authors:  Suzanne E Beck; Carole L Marcus
Journal:  Sleep Med Clin       Date:  2009-09

Review 9.  Sleep-related breathing disorders. 6. Obstructive sleep apnoea syndrome in infants and children: established facts and unsettled issues.

Authors:  C Gaultier
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

Review 10.  Investigation and management of childhood sleep apnoea.

Authors:  Ds Urquhart
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.